Clinicians' Use of Intravaginal Boric Acid Maintenance Therapy for Recurrent Vulvovaginal Candidiasis and Bacterial Vaginosis

Anna Powell, Khalil G. Ghanem, Linda Rogers, Ashley Zinalabedini, Rebecca M. Brotman, Jonathan Zenilman, Susan Tuddenham

Research output: Contribution to journalArticlepeer-review

Abstract

A retrospective chart review characterized clinicians' use of maintenance intravaginal boric acid for women with recurrent vulvovaginal candidiasis or bacterial vaginosis. Average length of use was 13 months with high patient satisfaction and few adverse events. Prospective studies are needed to evaluate the efficacy of maintenance boric acid for these conditions.

Original languageEnglish (US)
Pages (from-to)810-812
Number of pages3
JournalSexually transmitted diseases
Volume46
Issue number12
DOIs
StatePublished - Dec 1 2019

ASJC Scopus subject areas

  • Dermatology
  • Public Health, Environmental and Occupational Health
  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Clinicians' Use of Intravaginal Boric Acid Maintenance Therapy for Recurrent Vulvovaginal Candidiasis and Bacterial Vaginosis'. Together they form a unique fingerprint.

Cite this